• Startseite
• generic
• Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

Company Moves: The Latest in the Global Generics Market - DCAT Value Chain Insights

4.6 (476) · € 17.00 · Auf Lager

Novartis’ decision to spin out Sandoz, its generics and biosimilars business, into a separate, stand-alone company is the latest move in the highly cost-competitive generics market. What was behind Novartis’ decision, and how does it fit with other recent deals?

Neuland Labs

MARKET REPORT - Survey Suggests Global Innovation to Recover Much More Quickly Than Expected in 2023

Fast Fashion Global Market Report 2023 - Research and Markets

How Venture Philanthropy Can Disrupt Health Care: Lessons from Civica Rx

Caterpillar to move global headquarters from Illinois to Texas

DCAT Value Chain Insights

From supply chains to value webs, Deloitte Insights

DCAT Value Chain Insights

Direct to Consumers (D2C) Company Trends in Retail

How is the US Bio/Pharma Market Performing? - DCAT Value Chain Insights

DCAT Value Chain Insights (@DCATvci) / X